All In Biotech

Drug Trial Radar · NCT03941548

Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata

A Randomized Parallel-Group Study to Evaluate the Efficacy and Tolerability of Two Dosing Regimens of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

Last checked: Nov 19, 2026Latest source record: Apr 5, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

66

Actual

Start

May 24, 2019

Primary completion

Apr 10, 2020

Study completion Apr 10, 2020

Sponsor

Lead sponsor
Concert PharmaceuticalsIndustry
Sponsor type
Industry
First posted
May 8, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the efficacy and tolerability of once-daily versus twice-daily dosing of CTP-543, in adult patients with chronic, moderate to severe alopecia areata.

Conditions

  • Alopecia Areata

Interventions

  • CTP-543Drug

    Administered as 12 mg tablets.

  • CTP-543 Matching PlaceboDrug

    Administered as tablets to aid treatment masking.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Relative Change From Baseline in Severity of Alopecia Tool (SALT) Score at Week 24Time frame: Baseline, Week 24

Locations

12 sites in 2 countries. Site status is shown where the registry gives one.

  • Colorado Center for Dermatology and Skin Surgery

    Centennial, Colorado

  • ForCare Clinical Research

    Tampa, Florida

  • The Indiana Clinical Trials Center, PC

    Plainfield, Indiana

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Austin Institute for Clinical Research, Inc.

    Pflugerville, Texas

  • SimcoDerm Medical and Surgical Dermatology Center

    Barrie, Ontario, Canada

  • Guelph Dermatology Research

    Guelph, Ontario, Canada

  • Dr Wei Jing Loo Medicine Professional Corporation

    London, Ontario, Canada

  • Lynderm Research Inc.

    Markham, Ontario, Canada

  • The Centre for Clinical Trials

    Oakville, Ontario, Canada

  • Research Toronto

    Toronto, Ontario, Canada

  • Innovaderm Research Inc.

    Montreal, Quebec, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.